FIG 3.

(A) Mean adjusted disease-specific survival for occult endometrial carcinoma. (B) Mean adjusted disease-specific survival for occult uterine sarcoma. (C) Mean adjusted disease-specific survival for occult leimyosarcoma. The survival curve in this figure for each surgical group reflects mean adjusted survival probability at each time point among patients in the sample. Each patient’s survival probability at a given time point was estimated based on her characteristics and regression Model 2 for disease-specific survival in Table 3, while assuming that she was in the LSH/LM, SAH, or TAH group, respectively. The sample average survival probability at each time point was then derived for each group. LSH/LM, laparoscopic supracervical hysterectomy/laparoscopic myomectomy; SAH, supracervical abdominal hysterectomy; TAH, total abdominal hysterectomy.